79 related articles for article (PubMed ID: 7926393)
1. [NMDA receptor antagonists in focal cerebral ischemia. An experimental model].
Nathal E; Miquelajauregui JM; Herreman F; Alvarado R; Romero V; Mateos Gomez JH
Gac Med Mex; 1993; 129(2):125-30. PubMed ID: 7926393
[TBL] [Abstract][Full Text] [Related]
2. [Effects of Ginkgo biloba extract against excitotoxicity induced by NMDA receptors and mechanism thereof].
Xiao ZY; Sun CK; Xiao XW; Lin YZ; Li S; Ma H; Song GR; Cheng R
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2479-84. PubMed ID: 17156678
[TBL] [Abstract][Full Text] [Related]
3. The glutamate antagonist MK-801 reduces focal ischemic brain damage in the rat.
Park CK; Nehls DG; Graham DI; Teasdale GM; McCulloch J
Ann Neurol; 1988 Oct; 24(4):543-51. PubMed ID: 2853604
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a competitive NMDA antagonist (D-CPPene) in feline focal cerebral ischemia.
Chen M; Bullock R; Graham DI; Frey P; Lowe D; McCulloch J
Ann Neurol; 1991 Jul; 30(1):62-70. PubMed ID: 1834008
[TBL] [Abstract][Full Text] [Related]
5. The competitive NMDA receptor antagonist CGP 40116 is a potent neuroprotectant in a rat model of focal cerebral ischemia.
Sauer D; Allegrini PR; Fagg GE
J Neural Transm Suppl; 1994; 43():81-9. PubMed ID: 7884410
[TBL] [Abstract][Full Text] [Related]
6. Combination therapy with MK-801 and alpha-phenyl-tert-butyl-nitrone enhances protection against ischemic neuronal damage in organotypic hippocampal slice cultures.
Barth A; Barth L; Newell DW
Exp Neurol; 1996 Oct; 141(2):330-6. PubMed ID: 8812169
[TBL] [Abstract][Full Text] [Related]
7. Short therapeutic window for MK-801 in transient focal cerebral ischemia in normotensive rats.
Margaill I; Parmentier S; Callebert J; Allix M; Boulu RG; Plotkine M
J Cereb Blood Flow Metab; 1996 Jan; 16(1):107-13. PubMed ID: 8530543
[TBL] [Abstract][Full Text] [Related]
8. The neuroprotective effect of the novel noncompetitive NMDA antagonist, FR115427 in focal cerebral ischemia in rats.
Katsuta K; Nakanishi H; Shirakawa K; Yoshida K; Takagi K; Tamura A
J Cereb Blood Flow Metab; 1995 Mar; 15(2):345-8. PubMed ID: 7860668
[TBL] [Abstract][Full Text] [Related]
9. The pre-ischaemic neuroprotective effect of a novel polyamine antagonist, N1-dansyl-spermine in a permanent focal cerebral ischaemia model in mice.
Li J; Henman MC; Doyle KM; Strbian D; Kirby BP; Tatlisumak T; Shaw GG
Brain Res; 2004 Dec; 1029(1):84-92. PubMed ID: 15533319
[TBL] [Abstract][Full Text] [Related]
10. NMDA receptor blockade fails to alter axonal injury in focal cerebral ischemia.
Yam PS; Dunn LT; Graham DI; Dewar D; McCulloch J
J Cereb Blood Flow Metab; 2000 May; 20(5):772-9. PubMed ID: 10826527
[TBL] [Abstract][Full Text] [Related]
11. Effect of N-methyl-d-aspartate receptor blockade on neuronal plasticity and gastrointestinal transit delay induced by ischemia/reperfusion in rats.
Calcina F; Barocelli E; Bertoni S; Furukawa O; Kaunitz J; Impicciatore M; Sternini C
Neuroscience; 2005; 134(1):39-49. PubMed ID: 15939544
[TBL] [Abstract][Full Text] [Related]
12. Comet assay as a novel approach for studying DNA damage in focal cerebral ischemia: differential effects of NMDA receptor antagonists and poly(ADP-ribose) polymerase inhibitors.
Giovannelli L; Cozzi A; Guarnieri I; Dolara P; Moroni F
J Cereb Blood Flow Metab; 2002 Jun; 22(6):697-704. PubMed ID: 12045668
[TBL] [Abstract][Full Text] [Related]
13. Comparative effects of the N-methyl-D-aspartate antagonist MK-801 and the calcium channel blocker KB-2796 on neurologic and metabolic recovery after spinal cord ischemia.
Danielisová V; Chavko M
Exp Neurol; 1998 Jan; 149(1):203-8. PubMed ID: 9454629
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of delayed neuronal death after mild focal ischemia in mice by inhibition of the caspase family.
Endres M; Namura S; Shimizu-Sasamata M; Waeber C; Zhang L; Gómez-Isla T; Hyman BT; Moskowitz MA
J Cereb Blood Flow Metab; 1998 Mar; 18(3):238-47. PubMed ID: 9498840
[TBL] [Abstract][Full Text] [Related]
15. [Protective effect of dl-3-n-butylphthalide on ischemic neurological damage and abnormal behavior in rats subjected to focal ischemia].
Liu XG; Feng YP
Yao Xue Xue Bao; 1995 Dec; 30(12):896-903. PubMed ID: 8712015
[TBL] [Abstract][Full Text] [Related]
16. Pre- and postischemic effects of the NMDA receptor antagonist dizocilpine maleate (MK-801) on collateral cerebral blood flow.
Robertson SC; Wetjen NM; Beer BJ; Loftus CM
J Neurosurg; 1997 Dec; 87(6):927-33. PubMed ID: 9384406
[TBL] [Abstract][Full Text] [Related]
17. Selective neurotoxicity induced by the ionophore lasalocid in rat dissociated cerebral cultures, involvement of the NMDA receptor/channel.
Safran N; Haring R; Gurwitz D; Shainberg A; Halili I; Levy A; Bogin E; Shahar A
Neurotoxicology; 1996; 17(3-4):883-95. PubMed ID: 9086512
[TBL] [Abstract][Full Text] [Related]
18. NMDA Receptor-dependent increase of cerebral glucose utilization after hypoxia-ischemia in the immature rat.
Gilland E; Hagberg H
J Cereb Blood Flow Metab; 1996 Sep; 16(5):1005-13. PubMed ID: 8784246
[TBL] [Abstract][Full Text] [Related]
19. Tissue plasminogen activator-induced ischemic injury is reversed by NMDA antagonist MK-801 in vivo.
Kilic E; Kilic U; Bahr M; Hermann DM
Neurodegener Dis; 2005; 2(2):49-55. PubMed ID: 16909047
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy of rosiglitazone, a peroxisome proliferator-activated receptor-gamma ligand, and NMDA receptor antagonist (MK-801) on experimental embolic stroke in rats.
Allahtavakoli M; Shabanzadeh A; Roohbakhsh A; Pourshanazari A
Basic Clin Pharmacol Toxicol; 2007 Nov; 101(5):309-14. PubMed ID: 17910613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
